Gain of Function Patent submitted for Coronavirus – mRNA vaccine model

On April 19, 2022 a patent application was filed by Ralph Baric et al, of University of North Carolina at Chapel Hill called “Methods for Producing Recombinant Coronavirus” which stated a method for producing an “infectious, replication defective coronavirus” called a nidovirus.  This engineered modification to the “common cold” coronavirus made it more pathogenic to humans, and thus is a gain of function manipulation potentially weaponising a virus. This work was funded by NIAID head by Dr Anthony Fauci.

This patent forms the basis for the mRNA vaccine model. “For vaccine purposes, these data indicate that robust gene order rearranged Coronaviruses can be assembled and used as safe heterologous vaccines in swine and other vertebrate”

A few months later the SARS virus “emerged” in China, creating a brand new disease!